• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-494通过靶向c-Myc抑制上皮性卵巢癌生长。

MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.

作者信息

Yuan Jialing, Wang Kana, Xi Mingrong

机构信息

Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China (mainland).

出版信息

Med Sci Monit. 2016 Feb 24;22:617-24. doi: 10.12659/msm.897288.

DOI:10.12659/msm.897288
PMID:26908019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4768945/
Abstract

BACKGROUND Epithelial ovarian cancer (EOC) is the most lethal malignant gynecological cancer. MicroRNAs (miRNAs) play important roles in the pathogenesis of ovarian cancer. The role of miR-494 in EOC has not been fully investigated. MATERIAL AND METHODS MiR-494 levels in ovarian cancer tissues and cells were tested by qRT-PCR. Cells were transfected with miR-494 mimics or miR-494 ASO by Lipofectamine. Bioinformatics algorithms from TargetScanHuman were used to predict the target genes of miR-494. The c-Myc protein level was assayed by Western blot. The interaction between miR-494 and c-Myc was confirmed by dual luciferase assays. RESULTS MiR-494 showed low levels in EOC tissues and cells. Overexpression of miR-494 inhibited cell growth and migration of EOC cells and vice versa. c-Myc is the targeted gene of miR-494. CONCLUSIONS MiR-494 has an anti-tumor role in EOC via c-Myc.

摘要

背景

上皮性卵巢癌(EOC)是最致命的妇科恶性肿瘤。微小RNA(miRNA)在卵巢癌的发病机制中起重要作用。miR-494在EOC中的作用尚未得到充分研究。

材料与方法

采用qRT-PCR检测卵巢癌组织和细胞中miR-494的水平。通过脂质体转染miR-494模拟物或miR-494反义寡核苷酸(ASO)转染细胞。使用TargetScanHuman的生物信息学算法预测miR-494的靶基因。通过蛋白质免疫印迹法检测c-Myc蛋白水平。通过双荧光素酶报告基因检测法确认miR-494与c-Myc之间的相互作用。

结果

miR-494在EOC组织和细胞中呈低水平表达。miR-494的过表达抑制了EOC细胞的生长和迁移,反之亦然。c-Myc是miR-494的靶基因。

结论

miR-494通过c-Myc在EOC中发挥抗肿瘤作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/297f9e02775d/medscimonit-22-617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/38d74c4fdf98/medscimonit-22-617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/121f02d85e87/medscimonit-22-617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/297f9e02775d/medscimonit-22-617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/38d74c4fdf98/medscimonit-22-617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/121f02d85e87/medscimonit-22-617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c8/4768945/297f9e02775d/medscimonit-22-617-g003.jpg

相似文献

1
MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.微小RNA-494通过靶向c-Myc抑制上皮性卵巢癌生长。
Med Sci Monit. 2016 Feb 24;22:617-24. doi: 10.12659/msm.897288.
2
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.miR-373靶向Rab22a癌基因可抑制卵巢癌的肿瘤侵袭和转移。
Oncotarget. 2014 Dec 15;5(23):12291-303. doi: 10.18632/oncotarget.2577.
3
MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.微小RNA-130b通过调控上皮性卵巢癌中的RUNX3发挥肿瘤抑制作用。
Gene. 2016 Jul 15;586(1):48-55. doi: 10.1016/j.gene.2016.04.001. Epub 2016 Apr 2.
4
MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.miR-135a 在卵巢上皮性癌中作为肿瘤抑制因子发挥作用,并调节 HOXA10 的表达。
Cell Signal. 2014 Jul;26(7):1420-6. doi: 10.1016/j.cellsig.2014.03.002. Epub 2014 Mar 6.
5
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.miR-206 通过阻断 c-Met/AKT/mTOR 信号通路抑制上皮性卵巢癌细胞的生长和侵袭。
Biomed Pharmacother. 2018 Aug;104:763-770. doi: 10.1016/j.biopha.2018.05.077. Epub 2018 May 29.
6
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.微小RNA-145靶向TRIM2并在上皮性卵巢癌中发挥肿瘤抑制功能。
Gynecol Oncol. 2015 Dec;139(3):513-9. doi: 10.1016/j.ygyno.2015.10.008. Epub 2015 Oct 16.
7
MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.MicroRNA-320 靶向丝裂原活化蛋白激酶 1 抑制上皮性卵巢癌细胞的增殖和侵袭。
Mol Med Rep. 2017 Dec;16(6):8530-8536. doi: 10.3892/mmr.2017.7664. Epub 2017 Sep 29.
8
MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.微小 RNA-145 通过直接靶向人卵巢癌细胞中的 c-Myc 发挥抑癌基因作用。
Technol Cancer Res Treat. 2014 Apr;13(2):161-8. doi: 10.7785/tcrt.2012.500367. Epub 2013 Aug 2.
9
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.微小RNA-211通过靶向细胞周期蛋白D1和细胞周期蛋白依赖性激酶6抑制上皮性卵巢癌的增殖和细胞周期进程。
Mol Cancer. 2015 Mar 11;14:57. doi: 10.1186/s12943-015-0322-4.
10
MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.微小RNA-150预测上皮性卵巢癌患者预后良好,并通过抑制转录抑制因子ZEB1来抑制细胞侵袭和转移。
PLoS One. 2014 Aug 4;9(8):e103965. doi: 10.1371/journal.pone.0103965. eCollection 2014.

引用本文的文献

1
Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions.重新评估组织因子途径抑制物2在肿瘤性和非肿瘤性病变中的作用
Cancers (Basel). 2025 Apr 25;17(9):1447. doi: 10.3390/cancers17091447.
2
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
3
Comparative analysis of the growth differences between hybrid Ningdu Yellow chickens and their parentals.

本文引用的文献

1
miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.微小RNA-494通过靶向胰岛素样生长因子1受体抑制上皮性卵巢癌的肿瘤生长。
Tumour Biol. 2016 Jun;37(6):7767-76. doi: 10.1007/s13277-015-4603-8. Epub 2015 Dec 22.
2
Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer.组织微小RNA-193b作为卵巢癌患者的新型生物标志物
Med Sci Monit. 2015 Dec 16;21:3929-34. doi: 10.12659/msm.895407.
3
Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.浆液性上皮性卵巢癌细胞中CDK16表达上调。
宁都黄鸡杂交后代与其亲本生长差异的比较分析
Poult Sci. 2024 Dec;103(12):104239. doi: 10.1016/j.psj.2024.104239. Epub 2024 Aug 22.
4
JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer.JAK1是结直肠癌中肿瘤及侵袭抑制性微小RNA 494-5p的新靶点。
Cancers (Basel). 2023 Dec 20;16(1):24. doi: 10.3390/cancers16010024.
5
Role of microRNA-494 in tumor progression.微小RNA-494在肿瘤进展中的作用。
Am J Transl Res. 2023 Nov 15;15(11):6342-6361. eCollection 2023.
6
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.MYC 癌基因:天然产物治疗癌症的可用药靶。
Aging Dis. 2024 Apr 1;15(2):640-697. doi: 10.14336/AD.2023.0520.
7
Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis.基于生物信息学分析鉴定预测骨肉瘤进展的候选 microRNA-mRNA 子网络。
Comput Math Methods Med. 2022 Sep 22;2022:1821233. doi: 10.1155/2022/1821233. eCollection 2022.
8
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.卵巢癌中失调的miRNA簇:对个性化医疗的重要意义。
Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov.
9
miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma.微小RNA作为滑膜肉瘤的生物标志物及可能的治疗策略
Front Pharmacol. 2022 Aug 8;13:881007. doi: 10.3389/fphar.2022.881007. eCollection 2022.
10
Linoleic Acid Upregulates Microrna-494 to Induce Quiescence in Colorectal Cancer.亚油酸通过上调 microRNA-494 诱导结直肠癌细胞静止
Int J Mol Sci. 2021 Dec 25;23(1):225. doi: 10.3390/ijms23010225.
Med Sci Monit. 2015 Nov 7;21:3409-14. doi: 10.12659/msm.894990.
4
MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.微小RNA-1271通过靶向细胞周期蛋白G1抑制卵巢癌生长。
Med Sci Monit. 2015 Oct 19;21:3152-8. doi: 10.12659/msm.895562.
5
HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion.HOTAIR与MAPK1相互作用调控卵巢癌skov3细胞的增殖、迁移和侵袭。
Med Sci Monit. 2015 Jun 28;21:1856-63. doi: 10.12659/MSM.893528.
6
miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.微小RNA-494通过靶向磷脂酰肌醇-3-激酶的磷酸酶和张力蛋白同源物促进肝细胞癌的细胞增殖、迁移和侵袭,并增强对索拉非尼的耐药性。
Oncol Rep. 2015 Aug;34(2):1003-10. doi: 10.3892/or.2015.4030. Epub 2015 Jun 4.
7
Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.miR-494 的异位表达通过调节 SIRT1 和 c-Myc 抑制了胰腺癌的增殖、侵袭和化疗耐药性。
Gene Ther. 2015 Sep;22(9):729-38. doi: 10.1038/gt.2015.39. Epub 2015 Apr 28.
8
MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88.微小RNA-940通过靶向髓样分化因子88抑制胰腺导管腺癌生长。
Cell Physiol Biochem. 2015;35(3):1167-77. doi: 10.1159/000373941. Epub 2015 Feb 6.
9
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.微小RNA-141通过靶向肝癌细胞中的肝细胞核因子-3β抑制细胞增殖和侵袭并促进细胞凋亡。
BMC Cancer. 2014 Nov 25;14:879. doi: 10.1186/1471-2407-14-879.